GlaxoSmithKline Pharmaceuticals informs about analyst meet

20 Jun 2025 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that an analyst meeting is scheduled on 20th and 25th June 2025 as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2648.65 29.25 (1.12%)
25-Feb-2026 13:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1759.55
Dr. Reddys Lab 1310.15
Cipla 1342.00
Zydus Lifesciences 914.70
Lupin 2293.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×